Showing results (61-70 of 72) with videos related to
Sort By:
Pageof 8
American Journal of Clinical and Experimental Urology|January 7, 2022
Patient derived models of bladder cancer enrich the signal of the tumor cell transcriptome facilitating the analysis of the tumor cell compartmentMichalis Mastri, Swathi Ramakrishnan, Shruti D Shah, et al.Oncotarget|December 22, 2017
Dietary folate levels alter the kinetics and molecular mechanism of prostate cancer recurrence in the CWR22 modelHayley C Affronti, Mark D Long, Spencer R Rosario, et al.Cancer Research|November 15, 2012
Definition of molecular determinants of prostate cancer cell bone extravasationSteven R Barthel, Danielle L Hays, Erika M Yazawa, et al.Human Heredity|January 23, 2019
Comparison of SureSelect and Nextera Exome Capture Performance in Single-Cell SequencingWendy J Huss, Qiang Hu, Sean T Glenn, et al.Nature Communications|June 6, 2020
Author Correction: LRIG1 is a pleiotropic androgen receptor-regulated feedback tumor suppressor in prostate cancerQiuhui Li, Bigang Liu, Hsueh-Ping Chao, et al.Science Advances|February 1, 2021
Ultradeep sequencing differentiates patterns of skin clonal mutations associated with sun-exposure status and skin cancer burdenLei Wei, Sean R Christensen, Megan E Fitzgerald, et al.Nature Communications|December 4, 2019
LRIG1 is a pleiotropic androgen receptor-regulated feedback tumor suppressor in prostate cancerQiuhui Li, Bigang Liu, Hsueh-Ping Chao, et al.The Prostate|October 3, 2006
Identification of genes potentially involved in the acquisition of androgen-independent and metastatic tumor growth in an autochthonous genetically engineered mouse prostate cancer modelSharon D Morgenbesser, Rajashree P McLaren, Brenda Richards, et al.Leukemia & Lymphoma|July 21, 2012
Development and characterization of a novel human Waldenström macroglobulinemia cell line: RPCI-WM1, Roswell Park Cancer Institute - Waldenström Macroglobulinemia 1Kasyapa S Chitta, Aneel Paulus, Sikander Ailawadhi, et al.Nature Communications|January 9, 2020
Pharmacological polyamine catabolism upregulation with methionine salvage pathway inhibition as an effective prostate cancer therapyHayley C Affronti, Aryn M Rowsam, Anthony J Pellerite, et al.Pageof 8